Cryoport (NASDAQ:CYRX) Trading Down 5.3%

Shares of Cryoport, Inc. (NASDAQ:CYRXGet Rating) fell 5.3% during trading on Tuesday . The stock traded as low as $17.88 and last traded at $17.93. 9,606 shares were traded during trading, a decline of 99% from the average session volume of 792,352 shares. The stock had previously closed at $18.93.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CYRX. B. Riley reduced their price target on shares of Cryoport from $55.00 to $30.00 and set a “buy” rating on the stock in a research report on Wednesday, November 16th. KeyCorp dropped their price objective on shares of Cryoport from $52.00 to $40.00 and set an “overweight” rating on the stock in a research note on Friday, November 4th. Needham & Company LLC dropped their price objective on shares of Cryoport from $49.00 to $28.00 and set a “buy” rating on the stock in a research note on Friday, November 4th. Finally, SVB Leerink dropped their price objective on shares of Cryoport from $45.00 to $28.00 and set an “outperform” rating on the stock in a research note on Friday, November 4th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat, Cryoport has an average rating of “Buy” and an average price target of $42.17.

Cryoport Price Performance

The business’s 50 day moving average is $24.10 and its 200 day moving average is $29.00. The company has a debt-to-equity ratio of 0.75, a current ratio of 14.96 and a quick ratio of 14.35.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Advisors Capital Management LLC grew its position in Cryoport by 54.0% in the 3rd quarter. Advisors Capital Management LLC now owns 75,763 shares of the consumer goods maker’s stock worth $1,516,000 after purchasing an additional 26,579 shares during the last quarter. Alpha Paradigm Partners LLC boosted its position in shares of Cryoport by 18.7% during the 3rd quarter. Alpha Paradigm Partners LLC now owns 69,575 shares of the consumer goods maker’s stock valued at $1,695,000 after acquiring an additional 10,970 shares in the last quarter. BNP Paribas Arbitrage SNC boosted its position in shares of Cryoport by 100.0% during the 3rd quarter. BNP Paribas Arbitrage SNC now owns 19,626 shares of the consumer goods maker’s stock valued at $478,000 after acquiring an additional 9,814 shares in the last quarter. Castleark Management LLC acquired a new stake in shares of Cryoport during the 3rd quarter valued at about $1,591,000. Finally, Two Sigma Advisers LP acquired a new stake in shares of Cryoport during the 3rd quarter valued at about $431,000. Institutional investors own 90.33% of the company’s stock.

About Cryoport

(Get Rating)

Cryoport, Inc, a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle.

See Also

Receive News & Ratings for Cryoport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryoport and related companies with MarketBeat.com's FREE daily email newsletter.